Biblio

Export 551 results:
[ Author(Asc)] Title Type Year
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
E. Avondino and Antoine, P., Heterogeneity of Cognitive Anosognosia and its Variation with the Severity of Dementia in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 1, pp. 89-99, 2016.
E. Audronyte, Pakulaite-Kazliene, G., Sutnikiene, V., and Kaubrys, G., Odor Discrimination as a Marker of Early Alzheimer's Disease., J Alzheimers Dis, vol. 94, no. 3, pp. 1169-1178, 2023.
C. S. Atwood and Perry, G., Playing Russian Roulette with Alzheimer's Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema, Stroke and Encephalitis?, J Alzheimers Dis, vol. 92, no. 3, pp. 799-801, 2023.
B. Atanasova, Mondon, K., Dreyfuss, L., Beaufils, E., Desmidt, T., Hommet, C., El-Hage, W., and Belzung, C., Hedonic Assessment of Odors: A Comparison of Two Sensory Scales for Use with Alzheimer's Disease Patients and Elderly Individuals., J Alzheimers Dis, vol. 61, no. 3, pp. 929-938, 2018.
E. Aso, Andrés-Benito, P., Carmona, M., Maldonado, R., and Ferrer, I., Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine., J Alzheimers Dis, vol. 51, no. 2, pp. 489-500, 2016.
A. Arner, Rockenstein, E., Mante, M., Florio, J., Masliah, D., Salehi, B., Adame, A., Overk, C., Masliah, E., and Rissman, R. A., Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau., J Alzheimers Dis, vol. 61, no. 3, pp. 1201-1219, 2018.
B. A. Ardekani, Convit, A., and Bachman, A. H., Analysis of the MIRIAD Data Shows Sex Differences in Hippocampal Atrophy Progression., J Alzheimers Dis, vol. 50, no. 3, pp. 847-57, 2016.
D. Andriuta, Moullart, V., Schraen, S., Devendeville, A., Meyer, M. - E., and Godefroy, O., What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?, J Alzheimers Dis, vol. 51, no. 3, pp. 793-800, 2016.
M. J. Andersson and Stone, J., Best Medicine for Dementia: The Life-Long Defense of the Brain., J Alzheimers Dis, vol. 94, no. 1, pp. 51-66, 2023.
N. Altomari, Bruno, F., Laganà, V., Smirne, N., Colao, R., Curcio, S., Di Lorenzo, R., Frangipane, F., Maletta, R., Puccio, G., and Bruni, A. Cecilia, A Comparison of Behavioral and Psychological Symptoms of Dementia (BPSD) and BPSD Sub-Syndromes in Early-Onset and Late-Onset Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 691-699, 2022.
M. L. Alosco, Duskin, J., Besser, L. M., Martin, B., Chaisson, C. E., Gunstad, J., Kowall, N. W., McKee, A. C., Stern, R. A., and Tripodis, Y., Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set., J Alzheimers Dis, vol. 57, no. 3, pp. 953-968, 2017.
O. Almkvist, Larsson, M., and Graff, C., Odor Identification Across Time in Mutation Carriers and Non-Carriers in Autosomal-Dominant Alzheimer's Disease., J Alzheimers Dis, vol. 97, no. 2, pp. 587-598, 2024.
S. L. Allison, Fagan, A. M., Morris, J. C., and Head, D., Spatial Navigation in Preclinical Alzheimer's Disease., J Alzheimers Dis, vol. 52, no. 1, pp. 77-90, 2016.
H. B. Allen, A Novel Approach to the Treatment and Prevention of Alzheimer's Disease Based on the Pathology and Microbiology., J Alzheimers Dis, vol. 84, no. 1, pp. 61-67, 2021.
D. L. Alkon, Sun, M. - K., Tuchman, A. J., and Thompson, R. E., Advanced Alzheimer's Disease Patients Show Safe, Significant, and Persistent Benefit in 6-Month Bryostatin Trial., J Alzheimers Dis, vol. 96, no. 2, pp. 759-766, 2023.
M. Alegret, Peretó, M., Pérez, A., Valero, S., Espinosa, A., Ortega, G., Hernandez, I., Mauleón, A., Rosende-Roca, M., Vargas, L., Rodríguez-Gómez, O., Abdelnour, C., Berthier, M. L., Bak, T. H., Ruiz, A., Tárraga, L., and Boada, M., The Role of Verb Fluency in the Detection of Early Cognitive Impairment in Alzheimer's Disease., J Alzheimers Dis, vol. 62, no. 2, pp. 611-619, 2018.
M. S. Albert, DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., Snyder, P. J., Carrillo, M. C., Thies, B., and Phelps, C. H., The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease., Alzheimers Dement, vol. 7, no. 3, pp. 270-9, 2011.
P. S. Aisen, Andrieu, S., Sampaio, C., Carrillo, M., Khachaturian, Z. S., Dubois, B., Feldman, H. H., Petersen, R. C., Siemers, E., Doody, R. S., Hendrix, S. B., Grundman, M., Schneider, L. S., Schindler, R. J., Salmon, E., Potter, W. Z., Thomas, R. G., Salmon, D., Donohue, M., Bednar, M. M., Touchon, J., and Vellas, B., Report of the task force on designing clinical trials in early (predementia) AD., Neurology, vol. 76, no. 3, pp. 280-6, 2011.
B. Ahlemeyer, Halupczok, S., Rodenberg-Frank, E., Valerius, K. - P., and Baumgart-Vogt, E., Endogenous Murine Amyloid-β Peptide Assembles into Aggregates in the Aged C57BL/6J Mouse Suggesting These Animals as a Model to Study Pathogenesis of Amyloid-β Plaque Formation., J Alzheimers Dis, vol. 61, no. 4, pp. 1425-1450, 2018.
J. Ahdidan, Raji, C. A., DeYoe, E. A., Mathis, J., Noe, K. Ø., Rimestad, J., Kjeldsen, T. K., Mosegaard, J., Becker, J. T., and Lopez, O., Quantitative Neuroimaging Software for Clinical Assessment of Hippocampal Volumes on MR Imaging., J Alzheimers Dis, vol. 49, no. 3, pp. 723-32, 2016.
S. Agostini, Mancuso, R., Baglio, F., Cabinio, M., Hernis, A., Guerini, F. Rosa, Calabrese, E., Nemni, R., and Clerici, M., Lack of evidence for a role of HHV-6 in the pathogenesis of Alzheimer's disease., J Alzheimers Dis, vol. 49, no. 1, pp. 229-35, 2016.

Pages